Health service leaders in England are raising alarms about the sustainability of autism and ADHD care systems, citing escalating costs and inconsistent quality oversight among rapidly expanding private and charitable providers.
The NHS Alliance, which represents health managers, has characterized the current arrangement as unfavorable for both patients and taxpayers. The organization identified substantial disparities in pricing for similar services, with one local health board reporting charges ranging from £300 to £3,000. Several integrated care boards have described spending increases as exceeding controllable levels. One board experienced a ten-fold rise in costs to £1.5 million monthly, while another saw annual expenditures jump from £4 million to £30 million over two years. In the Cheshire and Merseyside region, adult ADHD spending rose from £11 million in 2023-24 to a projected £51 million in the current period.
The expansion has been driven partly by the right to choose policy, which allows patients to access care from both NHS and independent providers, intended to circumvent lengthy waiting lists. However, this has created rapid proliferation of new providers. One board reported engagement with 48 different providers, compared to a baseline of approximately 12 two years prior. Unlike standardized pricing structures for procedures such as joint replacements, autism and ADHD services lack mandatory tariffs, allowing providers to charge widely varying amounts. Additionally, assessment-only providers operate without registration requirements from the Care Quality Commission, complicating oversight efforts.
The government has indicated that an independent review examining service delivery and factors underlying increased diagnosis rates will be completed soon, with plans for a revised national strategy announced to follow. The Independent Healthcare Providers Network maintained that private sector involvement supplies essential capacity and innovation. The National Autistic Society characterized the situation as a system in crisis, attributing rising expenditures to inadequate long-term investment despite ongoing substantial spending and persistent patient delays.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI